HTG Molecular Diagnostics, Inc. (HTGMQ)

HTG Molecular Diagnostics Revenue

HTG Molecular Diagnostics had revenue of $3.47M in the twelve months ending September 30, 2023, down -48.97% year-over-year. In the year 2022, HTG Molecular Diagnostics had annual revenue of $6.37M, a decrease of -28.52%.

• Revenue (ttm): $3.47M
• Revenue Growth: -48.97%
• P/S Ratio: 0.00
• Revenue / Employee: $65,506
• Employees: 53
• Market Cap: 5.54K USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	6.37M	-2.54M	-28.52%
Dec 31, 2021	8.91M	357.96K	4.19%
Dec 31, 2020	8.55M	-10.66M	-55.48%
Dec 31, 2019	19.20M	-2.30M	-10.70%
Dec 31, 2018	21.50M	6.74M	45.69%
Dec 31, 2017	14.76M	9.63M	187.56%
Dec 31, 2016	5.13M	1.09M	27.00%
Dec 31, 2015	4.04M	712.62K	21.41%
Dec 31, 2014	3.33M	1.09M	48.41%
Dec 31, 2013	2.24M	-237.78K	-9.58%
Dec 31, 2012	2.48M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.